The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Systematic overview of warfarin and its drug and food interactions
Holbrook, A. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1095 · Cited by 1,160
Writing Committee Members, Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., & Quigley, E. M. (2008) · Circulation · doi:10.1161/circulationaha.108.191087 · Cited by 843
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Human P450 metabolism of warfarin
Kaminsky, L. S., & Zhang, Z.-Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00140-4 · Cited by 798
Goetz, M. P., Rae, J. M., Suman, V. J., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., Flockhart, D. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3266 · Cited by 791
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A. (2003) · JAMA · doi:10.1001/jama.289.13.1652 · Cited by 761
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
Palmer, B. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035279 · Cited by 640
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen
Goetz, M. P., Knox, S. K., Suman, V. J., Rae, J. M., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9428-0 · Cited by 552
The challenge of managing drug interactions in elderly people
Mallet, L., Spinewine, A., & Huang, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61092-7 · Cited by 537
Schroth, W. (2009) · JAMA · doi:10.1001/jama.2009.1420 · Cited by 531
The cognitive impact of anticholinergics: A clinical review
Malaz Boustani, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s5358 · Cited by 479
Schroth, W., Antoniadou, L., Fritz, P., Schwab, M., Muerdter, T., Zanger, U. M., Simon, W., Eichelbaum, M., & Brauch, H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2705 · Cited by 467
Kelly, C. M., Juurlink, D. N., Gomes, T., Duong-Hua, M., Pritchard, K. I., Austin, P. C., & Paszat, L. F. (2010) · BMJ · doi:10.1136/bmj.c693 · Cited by 466
Johnell, K., & Klarin, I. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00009 · Cited by 386
Pharmacokinetic Drug Interactions of Macrolides
Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223020-00004 · Cited by 358
Benzodiazepines and Risk of Hip Fractures in Older People: A Review of the Evidence
Cumming, R. G., & Le Couteur, D. G. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00004 · Cited by 332
Shorr, R. I. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.14.1665 · Cited by 324
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Zolpidem Use and Hip Fractures in Older People
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2001.49280.x · Cited by 272
Pharmacodynamics in Older Adults: A Review
Bowie, M. W., & Slattum, P. W. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.10.001 · Cited by 266
Pharmacokinetics in older persons
Cusack, B. J. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2004.12.005 · Cited by 253
Westphal, J. F. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00261.x · Cited by 217
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204
Urichuk, L., Prior, T., Dursun, S., & Baker, G. (2008) · Current Drug Metabolism · doi:10.2174/138920008784746373 · Cited by 204
Grandjean, E. M., & Aubry, J.-M. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00005 · Cited by 203
Understanding and preventing drug interactions in elderly patients
Delafuente, J. C. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.04.004 · Cited by 196
Malone, D. C., Armstrong, E. P., Abarca, J., Grizzle, A. J., Hansten, P. D., Van Bergen, R. C., Duncan-Edgar, B. S., Solomon, S. L., & Lipton, R. B. (2004) · Journal of the American Pharmacists Association · doi:10.1331/154434504773062591 · Cited by 187
Drug‐Induced Lithium Toxicity in the Elderly: A Population‐Based Study
Juurlink, D. N., Mamdani, M. M., Kopp, A., Rochon, P. A., Shulman, K. I., & Redelmeier, D. A. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52221.x · Cited by 179
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively
Wen, X., Wang, J.-S., Backman, J. T., Laitila, J., & Neuvonen, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.631 · Cited by 173
Battistella, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.189 · Cited by 162
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
Sideras, K., Ingle, J. N., Ames, M. M., Loprinzi, C. L., Mrazek, D. P., Black, J. L., Weinshilboum, R. M., Hawse, J. R., Spelsberg, T. C., & Goetz, M. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8931 · Cited by 155
Antoniou, T., Gomes, T., Juurlink, D. N., Loutfy, M. R., Glazier, R. H., & Mamdani, M. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.142 · Cited by 155
Schelleman, H., Bilker, W., Brensinger, C. M., Han, X., Kimmel, S. E., & Hennessy, S. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.150 · Cited by 134
ABERNETHY, D. R., Schwartz, J. B., Todd, E. L., Luchi, R. J., & Snow, E. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-329 · Cited by 125
Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation
Zhang, Z., & Kaminsky, L. S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00120-o · Cited by 124
Zint, K., Haefeli, W. E., Glynn, R. J., Mogun, H., Avorn, J., & Stürmer, T. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2031 · Cited by 122
Assessment of potential drug–drug interactions with a prescription claims database
Malone, D. C., Hutchins, D. S., Haupert, H., Hansten, P. D., Duncan, B. S., Bergen, R. C. V., Solomon, S. L., & Lipton, R. B. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040567 · Cited by 122
Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly
Vieweg, W. V. R., Wood, M. A., Fernandez, A., Beatty-Brooks, M., Hasnain, M., & Pandurangi, A. K. (2009) · Drugs & Aging · doi:10.2165/11318880-000000000-00000 · Cited by 121
Role of P-Glycoprotein Inhibition for Drug Interactions
Eberl, S., Renner, B., Neubert, A. C., Reisig, M., Bachmakov, I., König, J., Dörje, F., Mürdter, T. E., Ackermann, A., Dormann, H., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746120-00004 · Cited by 120
Theophylline toxicity: Clinical features of 116 consecutive cases
Sessler, C. N. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90519-j · Cited by 119
Severe Dysglycemia with the Fluoroquinolones: A Class Effect?
Aspinall, S. L., Good, C. B., Jiang, R., McCarren, M., Dong, D., & Cunningham, F. E. (2009) · Clinical Infectious Diseases · doi:10.1086/600294 · Cited by 111
Crowley, J. J., Cusack, B. J., Jue, S. G., Koup, J. R., Park, B. K., & Vestal, R. E. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22660-x · Cited by 105
Zhan, C., Correa‐de‐Araujo, R., Bierman, A. S., Sangl, J., Miller, M. R., Wickizer, S. W., & Stryer, D. B. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53112.x · Cited by 97
Wright, A. J., Gomes, T., Mamdani, M., Horn, J. R., & Juurlink, D. N. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.100702 · Cited by 95
Age and phenytoin kinetics in adult epileptics
Bauer, L. A., & Blouin, R. A. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.37 · Cited by 93
Fischer, H. D., Juurlink, D. N., Mamdani, M., Kopp, A., & Laupacis, A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.37 · Cited by 90
Anti-Infectives and the Risk of Severe Hypoglycemia in Users of Glipizide or Glyburide
Schelleman, H., Bilker, W. B., Brensinger, C. M., Wan, F., & Hennessy, S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.74 · Cited by 86
Truitt, E. B., Morgan, A. M., & Little, J. M. (1955) · Journal of the American Pharmaceutical Association (Scientific ed ) · doi:10.1002/jps.3030440306 · Cited by 85
The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
Dubuske, L. (2005) · Drug Safety · doi:10.2165/00002018-200528090-00004 · Cited by 84
Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide
Lilja, J. J., Niemi, M., Fredrikson, H., & Neuvonen, P. J. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02836.x · Cited by 79
Drug Interactions Analysis and Management 2009
Ranieri, M. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181c0d593 · Cited by 78
Drug interactions during therapy with three major groups of antimicrobial agents
Shakeri‐Nejad, K., & Stahlmann, R. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.639 · Cited by 77
Antidepressants: Clinically Relevant Drug Interactions to Be Considered
Schellander, R., & Donnerer, J. (2010) · Pharmacology · doi:10.1159/000319744 · Cited by 76
The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
Batty, K. T., Davis, T. M. E., Ilett, K., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04453.x · Cited by 74
Hauta-Aho, M., Tirkkonen, T., Vahlberg, T., & Laine, K. (2009) · Annals of Medicine · doi:10.1080/07853890903186168 · Cited by 67
Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions
Holstein, A., & Beil, W. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902806424 · Cited by 64
Cheetham, T. C., Levy, G. D., Niu, F., & Bixler, F. R. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m284 · Cited by 64
The Use of Oral Anticoagulants (warfarin) in Older People
(2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03917.x · Cited by 64
Quality of Pharmacotherapy and Outcomes for Older Veterans Discharged from the Emergency Department
Hastings, S. N., Schmader, K. E., Sloane, R. J., Weinberger, M., Pieper, C. F., Goldberg, K. C., & Oddone, E. Ž. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01648.x · Cited by 49
Taipale, H. T., Hartikainen, S. A., & Bell, J. S. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.10.004 · Cited by 46
Delafuente, J. C., & Stewart, R. B. (1988) · Williams & Wilkins eBooks · Cited by 44
Ciprofloxacin-induced theophylline toxicity: a population-based study
Antoniou, T., Gomes, T., Mamdani, M., & Juurlink, D. N. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0985-0 · Cited by 43
French, D. D., Chirikos, T. N., Spehar, A. M., Campbell, R. R., Means, H., & Bulat, T. (2005) · Drug Safety · doi:10.2165/00002018-200528120-00008 · Cited by 42
Trimethoprim/sulfamethoxazole‐induced phenytoin toxicity in the elderly: a population‐based study
Antoniou, T., Gomes, T., Mamdani, M., & Juurlink, D. N. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03866.x · Cited by 37
Loi, C., Parker, B. M., Cusack, B. J., & Vestal, R. E. (1997) · PubMed · Cited by 37
Dysglycaemias and Fluoroquinolones
Lewis, R. J., & Mohr, J. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00002 · Cited by 35
LaPlante, K. L., Mersfelder, T. L., Ward, K. E., & Quilliam, B. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.1.82 · Cited by 32
The Use of Oral Anticoagulants (Warfarin) in Older People
(2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50380.x · Cited by 31
Lithium Intoxication After Administration of AT1 Blockers
Zwanzger, P., Marcuse, A., Boerner, R. J., Walther, A., & Rupprecht, R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0312e · Cited by 25
Vestal, R. E., Cusack, B. J., MERCER, G. D., Dawson, G., & Park, B. K. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00297-6 · Cited by 25
Chan, A. L. F., Wang, M., Su, C.-Y., & Tsai, F.-H. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0698-4 · Cited by 23
Loi, C., Parker, B. M., Cusack, B. J., & Vestal, R. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36457-2 · Cited by 22
Effect of Disease States on Theophylline Serum Concentrations: Are We Still Vigilant?
Self, T. H., Chafin, C. C., & Soberman, J. E. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40716-5 · Cited by 18
Aging and the response to inhibition and induction of theophylline metabolism
Vestal, R. E., Cusack, B. J., Crowley, J. J., & Loi, C. (1993) · Experimental Gerontology · doi:10.1016/0531-5565(93)90068-o · Cited by 10
Cited by
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
“Drug–Drug Interactions New to the AGS Beers Criteria are drug–drug interactions (excluding anti-infectives) that are highly associated with harmful outcomes in older adults.(12) The list is selective, and not comprehensive, and is not intended to diminish the clinical importance of known drug–drug interactions not lis…”
BackgroundKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Age-related changes in body composition can result in increases or decreases of drug volume distribution, and hepatic or renal dysfunction can impair drug metabolism and drug clearance [1369,1370].”
BackgroundInfluentialBuford, T. W. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.007 · Cited by 561
Miner, B., & Kryger, M. H. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.10.008 · Cited by 407
Motter, F. R., Fritzen, J. S., Hilmer, S. N., Paniz, É. V., & Paniz, V. M. V. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2446-0 · Cited by 276
Metadata
- Authors
- Hines, L. E., & Murphy, J. E.
- Venue
- The American Journal of Geriatric Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 9
- Issue
- 6
- Pages
- 364-377
- ISSN
- 1543-5946 (ISSN-L)
- OpenAlex
- W2079953715
- Cited by
- 272
- References
- 78
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.